Equilibrative nucleoside transporter 1 deletion confers neuroprotection via augmented lymphatic drainage in a mouse model of ischemic stroke

The meningeal lymphatic system drains immune-related components from the cerebrospinal fluid to the deep cervical lymph nodes (dCLNs), thereby modulating neuroinflammation and stroke-induced neuropathological changes. Ischemic stroke markedly increases extracellular adenosine levels in the brain, and equilibrative nucleoside transporter 1 (Ent1), a principal regulator of adenosine homeostasis, is highly expressed in dural endothelial cells. To examine the role of Ent1 in meningeal lymphatic vessel (mLV) remodeling and post-stroke neuroimmune responses, Ent1 knockout (Ent1 −/− ) mice and littermate controls were subjected to permanent middle cerebral artery occlusion (pMCAO). mLV remodeling was evaluated by measuring mLV branch points and coverage area using immunofluorescence staining of the mLVs for lymphatic vessel endothelial hyaluronan receptor-1. Lymphatic drainage function was assessed by quantifying fluorescent microsphere accumulation in the dura and dCLNs following intra-cisterna magna injection. Neuroinflammation, brain microvascular integrity, infarct volume, edema, and functional recovery were also quantified. Our results showed that genetic ablation of Ent1 markedly promoted mLV remodeling and enhanced drainage function. Consequently, Ent1 −/− mice exhibited reduced infarct volume and edema, attenuated neuroinflammation, preserved blood–brain barrier integrity, and improved motor and cognitive recovery following pMCAO. Notably, surgical ligation of the dCLNs, which disrupts meningeal lymphatic drainage, abolished the protective effects against infarct expansion and edema, underscoring the dependence on an intact meningeal lymphatic–dCLNs pathway. Additionally, pharmacological inhibition of Ent1 improved mLV remodeling and drainage function in mice with pMCAO. Collectively, these findings identify Ent1 as a key regulator of meningeal immune clearance and highlight its potential as a therapeutic target to enhance lymphatic function and restrain neuroinflammation in ischemic stroke.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.1958817
Primary Topic
Lymphatic System and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Equilibrative nucleoside transporter 1 deletion confers neuroprotection via augmented lymphatic drainage in a mouse model of ischemic stroke

Chin‐Jui Ho, Houng‐Chi Liou, Hui-Ling Chiang, Wen-Yu Chen et al.
Frontiers in Immunology
Lymphatic System and Diseases
article

Equilibrative nucleoside transporter 1 deletion confers neuroprotection via augmented lymphatic drainage in a mouse model of ischemic stroke

Chin‐Jui Ho, Houng‐Chi Liou, Hui-Ling Chiang, Wen-Yu Chen, Chun-Jung Lin, Ying-Chu Chen
article en

Abstract

The meningeal lymphatic system drains immune-related components from the cerebrospinal fluid to the deep cervical lymph nodes (dCLNs), thereby modulating neuroinflammation and stroke-induced neuropathological changes. Ischemic stroke markedly increases extracellular adenosine levels in the brain, and equilibrative nucleoside transporter 1 (Ent1), a principal regulator of adenosine homeostasis, is highly expressed in dural endothelial cells. To examine the role of Ent1 in meningeal lymphatic vessel (mLV) remodeling and post-stroke neuroimmune responses, Ent1 knockout (Ent1 −/− ) mice and littermate controls were subjected to permanent middle cerebral artery occlusion (pMCAO). mLV remodeling was evaluated by measuring mLV branch points and coverage area using immunofluorescence staining of the mLVs for lymphatic vessel endothelial hyaluronan receptor-1. Lymphatic drainage function was assessed by quantifying fluorescent microsphere accumulation in the dura and dCLNs following intra-cisterna magna injection. Neuroinflammation, brain microvascular integrity, infarct volume, edema, and functional recovery were also quantified. Our results showed that genetic ablation of Ent1 markedly promoted mLV remodeling and enhanced drainage function. Consequently, Ent1 −/− mice exhibited reduced infarct volume and edema, attenuated neuroinflammation, preserved blood–brain barrier integrity, and improved motor and cognitive recovery following pMCAO. Notably, surgical ligation of the dCLNs, which disrupts meningeal lymphatic drainage, abolished the protective effects against infarct expansion and edema, underscoring the dependence on an intact meningeal lymphatic–dCLNs pathway. Additionally, pharmacological inhibition of Ent1 improved mLV remodeling and drainage function in mice with pMCAO. Collectively, these findings identify Ent1 as a key regulator of meningeal immune clearance and highlight its potential as a therapeutic target to enhance lymphatic function and restrain neuroinflammation in ischemic stroke.

Frontiers in ImmunologyVol. 17
National Taiwan University (TW)
Good health and well-being
Lymphatic System and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon